NGL Fine Chem logo

NGL Fine Chem

NGLFINE NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹1,653 Cr
Volatility
Moderate
P/E Ratio
32.54
EBITDA
₹87.40 Cr
Return on Equity
14.62%
Debt to Equity
0.38
Book Value
₹532.75
52W High
₹3,602
52W Low
₹1,271

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

2
  • Stock is trading at 5.13 times its book value
  • Company has a low return on equity of 12.7% over last 3 years.

Growth Rate

Revenue Growth
36.83% higher than 3Y
Net Income Growth
128% higher than 3Y
Cash Flow Change
33.91% lower than 3Y
ROE
95.45% higher than 3Y
ROCE
80.53% higher than 3Y
EBITDA Margin (Avg.)
50.27% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
69
79
85
96
88
91
87
93
101
117
126
145
137
Expenses
62
66
74
83
82
81
83
89
93
103
106
127
117
Operating Profit
8
13
11
13
6
11
4
4
8
14
20
18
20
OPM %
11%
17%
13%
13%
7%
12%
4.1%
4.2%
8%
12%
16%
12%
14%
Other Income
4
4
4
4
6
5
0
-1
7
2
5
3
7
Interest
0
0
0
0
0
0
1
1
1
1
1
1
1
Depreciation
2
2
2
2
2
2
2
3
3
4
4
4
4
PBT
9
15
13
14
10
13
1
0
10
11
19
15
22
Tax %
15%
24%
30%
24%
22%
25%
4%
44%
21%
26%
24%
24%
24%
Net Profit
8
11
9
11
8
10
1
-1
8
8
15
11
16
EPS in Rs
12.64
17.76
14.41
17.56
12.67
16.25
1.26
-0.84
12.37
12.79
23.86
18.37
26.63
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
88
96
100
114
153
152
258
319
275
329
359
489
525
Expenses
73
74
74
92
121
129
181
253
246
284
332
421
454
Operating Profit
15
22
25
22
32
23
77
66
29
45
27
68
71
OPM %
17%
23%
26%
19%
21%
15%
30%
21%
10%
14%
7%
14%
14%
Other Income
2
0
1
3
4
1
9
13
8
16
10
8
17
Interest
2
2
1
2
3
3
2
2
2
2
3
5
4
Depreciation
3
3
3
5
6
7
7
8
8
8
9
16
17
PBT
13
18
23
18
28
14
76
69
27
51
24
55
67
Tax %
35%
36%
35%
29%
27%
26%
27%
24%
24%
24%
24%
24%
—
Net Profit
8
11
15
13
20
11
55
52
20
39
18
42
50
EPS in Rs
13.48
18.45
24.1
20.38
32.58
17.16
89.79
84.57
32.57
62.35
29.35
67.38
81.65
Div. Payout %
0%
0%
0%
0%
5%
10%
2%
2%
5%
3%
6%
3%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3
3
3
3
3
3
3
3
3
3
3
3
Reserves
30
41
56
69
89
98
152
203
222
260
277
317
Borrowings
13
14
23
27
27
28
16
30
32
34
77
122
Other Liabilities
21
19
20
31
23
26
34
41
30
56
70
88
Total Liabilities
67
78
102
129
142
156
206
278
288
353
426
530
Fixed Assets
17
24
25
56
61
61
58
59
59
60
120
144
CWIP
1
2
16
3
0
0
1
6
26
46
50
95
Investments
2
3
6
6
9
14
33
32
43
57
63
43
Other Assets
46
49
55
63
73
80
115
180
159
190
193
248
Total Assets
67
78
102
129
142
156
206
278
288
353
426
530
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
8
8
10
22
9
20
27
13
32
11
22
35
Investing
-3
-10
-10
-21
-10
-19
-24
-13
-24
-17
-58
-65
Financing
-4
2
0
0
0
-1
-1
-1
-1
-1
36
30
Net Cash Flow
1
0
0
1
-1
0
2
-1
7
-7
0
0
Free Cash Flow
5
-2
-8
-1
-6
12
22
-2
3
-17
-51
-51
CFO/OP
80
68
70
128
50
101
61
45
134
52
104
70
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
107
123
110
89
79
63
53
74
86
92
81
94
Inventory Days
106
90
114
134
106
154
132
133
69
99
95
101
Days Payable
150
122
139
187
92
114
94
84
59
110
94
89
Cash Conversion Cycle
63
91
85
35
93
103
91
124
97
82
83
106
Working Capital Days
38
49
45
18
70
63
71
89
67
71
51
59
ROCE %
29%
37%
34%
22%
28%
15%
52%
35%
12%
19%
8%
17%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view NGL Fine Chem insights

68 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

DIIs0.02%Promot.72.49%FIIs0.05%Others4.81%Public22.63%As ofJun 2026

Documents

Frequently Asked Questions about NGL Fine Chem

What does NGL Fine Chem Ltd do?
Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]
Where is NGL Fine Chem Ltd (NGLFINE) listed?
NGL Fine Chem Ltd trades as NGLFINE on the NSE and under code 524774 on the BSE.
Which sector does NGL Fine Chem Ltd belong to?
NGL Fine Chem Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of NGL Fine Chem Ltd?
NGL Fine Chem Ltd has a market capitalisation of ₹1,653 Cr, which places it in the Small Cap band.
What is the PE ratio of NGL Fine Chem Ltd?
NGL Fine Chem Ltd trades at a PE ratio of 32.54, against a book value of ₹532.75 per share.
What is the 52-week high and low of NGL Fine Chem Ltd?
Over the last 52 weeks NGL Fine Chem Ltd has traded between ₹1,271 and ₹3,602.
Does NGL Fine Chem Ltd pay dividends?
NGL Fine Chem Ltd has a dividend yield of 0.06%.
What is the Return on Equity (ROE) of NGL Fine Chem Ltd?
NGL Fine Chem Ltd reported a return on equity of 14.62%. Its debt-to-equity ratio is 0.38.

Company Information

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]

Website nglfinechem.com
CEO Mr. Rahul Jayant Nachane ACA, B. Com, DBF, MMS
Employees 520
Listed 2022-07-08
Face Value ₹ 5
Issued Size 61,78,024

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NGLFINE.md for NGL Fine Chem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List